Screening Study of the Anxiolytic Activity of New Triazole Compounds

dc.contributor.authorS.D. Rakhimboev
dc.contributor.authorZ.I. Sanoev
dc.contributor.authorS.Z. Rashidov
dc.contributor.authorI.T. Abdinazarov
dc.contributor.authorT.T. Khamroev
dc.contributor.authorD.S. Ismailova
dc.contributor.authorB.J.Elmuradov
dc.date.accessioned2026-01-01T10:17:45Z
dc.date.issued2022-10-08
dc.description.abstractThe article presents data on the study of the anxiolytic activity of compounds representing new triazole derivatives – combinations of two privileged structures. At the "Raised Cruciform labyrinth" installation, such indicators of the studied compounds, the time of exit into the open sleeve, the number of exits and the total time spent in it were studied that the D-389 compounds are not inferior to the comparison drug, which indicates the presence of high anxiolytic activity.
dc.formatapplication/pdf
dc.identifier.urihttps://zienjournals.com/index.php/tjms/article/view/2450
dc.identifier.uri10.62480/tjms.2022.vol13.pp43-46
dc.identifier.urihttps://asianeducationindex.com/handle/123456789/59428
dc.language.isoeng
dc.publisherZien Journals
dc.relationhttps://zienjournals.com/index.php/tjms/article/view/2450/2056
dc.rightshttps://creativecommons.org/licenses/by-nc/4.0
dc.sourceTexas Journal of Medical Science; Vol. 13 (2022): TJMS; 43-46
dc.source2770-2936
dc.subjecttriazole compounds
dc.subjectseduxene
dc.subjectanxiolytic
dc.subjectraised cruciform labyrinth
dc.titleScreening Study of the Anxiolytic Activity of New Triazole Compounds
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.typePeer-reviewed Article

item.page.files

item.page.filesection.original.bundle

pagination.showing.labelpagination.showing.detail
loading.default
thumbnail.default.alt
item.page.filesection.name
rakhimboev_2022_screening_study_of_the_anxiolytic_activi.pdf
item.page.filesection.size
223.99 KB
item.page.filesection.format
Adobe Portable Document Format

item.page.collections